Operating Expenses Summary of Formosa Laboratories, Inc.

Formosa Laboratories, Inc.'s latest annual operating expenses in 2023 was 1.24 Billion TWD , up 2.5% from previous year.
Formosa Laboratories, Inc.'s latest quarterly operating expenses in 2024 Q2 was 350.5 Million TWD , up 0.62% from previous quarter.
Formosa Laboratories, Inc. reported a annual operating expenses of 1.19 Billion TWD in annual operating expenses 2022, up 3.9% from previous year.
Formosa Laboratories, Inc. reported a annual operating expenses of 1.15 Billion TWD in annual operating expenses 2021, up 30.11% from previous year.
Formosa Laboratories, Inc. reported a quarterly operating expenses of 350.5 Million TWD for 2024 Q2, up 0.62% from previous quarter.
Formosa Laboratories, Inc. reported a quarterly operating expenses of 1.22 Billion TWD for 2023 FY, up 2.5% from previous quarter.

Annual Operating Expenses Chart of Formosa Laboratories, Inc. (2023 - 2009)

Historical Annual Operating Expenses of Formosa Laboratories, Inc. (2023 - 2009)

Year	Operating Expenses	Operating Expenses Growth
2023	1.24 Billion TWD	2.5%
2022	1.19 Billion TWD	3.9%
2021	1.15 Billion TWD	30.11%
2020	886.42 Million TWD	11.99%
2019	791.53 Million TWD	-7.63%
2018	856.88 Million TWD	36.53%
2017	627.62 Million TWD	5.66%
2016	594.01 Million TWD	23.65%
2015	480.41 Million TWD	16.4%
2014	412.73 Million TWD	-0.39%
2013	414.36 Million TWD	16.97%
2012	354.23 Million TWD	3.79%
2011	341.31 Million TWD	23.37%
2010	276.65 Million TWD	0.0%
2009	- TWD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	354.34 Million TWD	24.01%
2024 Q2	350.5 Million TWD	0.62%
2023 FY	1.22 Billion TWD	2.5%
2023 Q4	285.74 Million TWD	-15.03%
2023 Q3	336.28 Million TWD	-2.07%
2023 Q2	343.4 Million TWD	12.29%
2023 Q1	305.81 Million TWD	-3.96%
2022 Q3	289.79 Million TWD	-1.41%
2022 Q1	296.18 Million TWD	17.14%
2022 FY	1.19 Billion TWD	3.9%
2022 Q4	318.42 Million TWD	9.88%
2022 Q2	293.94 Million TWD	-0.76%
2021 Q3	271.76 Million TWD	-19.34%
2021 Q2	336.92 Million TWD	15.47%
2021 FY	1.15 Billion TWD	30.11%
2021 Q1	291.78 Million TWD	93.19%
2021 Q4	252.86 Million TWD	-6.96%
2020 Q2	291.94 Million TWD	35.96%
2020 Q3	228.72 Million TWD	-21.66%
2020 FY	886.42 Million TWD	11.99%
2020 Q1	214.72 Million TWD	27.72%
2020 Q4	151.03 Million TWD	-33.96%
2019 Q2	198.79 Million TWD	-15.69%
2019 Q1	235.78 Million TWD	16.14%
2019 Q4	168.12 Million TWD	-10.97%
2019 Q3	188.83 Million TWD	-5.01%
2019 FY	791.53 Million TWD	-7.63%
2018 Q1	217.89 Million TWD	37.27%
2018 Q3	209.49 Million TWD	-7.5%
2018 Q4	203.02 Million TWD	-3.09%
2018 FY	856.88 Million TWD	36.53%
2018 Q2	226.47 Million TWD	3.94%
2017 Q3	164.45 Million TWD	-1.24%
2017 Q2	166.51 Million TWD	20.73%
2017 Q1	137.92 Million TWD	-7.19%
2017 FY	627.62 Million TWD	5.66%
2017 Q4	158.73 Million TWD	-3.48%
2016 Q2	154.13 Million TWD	3.82%
2016 FY	594.01 Million TWD	23.65%
2016 Q3	142.82 Million TWD	-7.34%
2016 Q1	148.45 Million TWD	2.72%
2016 Q4	148.6 Million TWD	4.05%
2015 Q4	144.52 Million TWD	26.94%
2015 Q2	108.13 Million TWD	-5.05%
2015 Q1	113.89 Million TWD	25.27%
2015 Q3	113.85 Million TWD	5.29%
2015 FY	480.41 Million TWD	16.4%
2014 Q1	97.93 Million TWD	-10.55%
2014 FY	412.73 Million TWD	-0.39%
2014 Q4	90.92 Million TWD	-21.16%
2014 Q3	115.31 Million TWD	6.22%
2014 Q2	108.56 Million TWD	10.85%
2013 Q4	109.49 Million TWD	-3.77%
2013 Q1	84.92 Million TWD	-5.02%
2013 Q2	106.16 Million TWD	25.01%
2013 FY	414.36 Million TWD	16.97%
2013 Q3	113.77 Million TWD	7.17%
2012 Q2	84.29 Million TWD	0.04%
2012 Q1	84.26 Million TWD	-11.21%
2012 Q3	96.37 Million TWD	14.33%
2012 Q4	89.41 Million TWD	-7.22%
2012 FY	354.23 Million TWD	3.79%
2011 Q1	75.8 Million TWD	-72.6%
2011 Q4	94.89 Million TWD	1.29%
2011 Q2	76.92 Million TWD	1.49%
2011 Q3	93.68 Million TWD	21.79%
2011 FY	341.31 Million TWD	23.37%
2010 Q4	276.65 Million TWD	0.0%
2010 Q1	- TWD	0.0%
2010 Q2	- TWD	0.0%
2010 FY	276.65 Million TWD	0.0%
2010 Q3	- TWD	0.0%
2009 FY	- TWD	0.0%

Peer Operating Expenses Comparison of Formosa Laboratories, Inc.

Name	Operating Expenses	Operating Expenses Difference
Grape King Bio Ltd	6.03 Billion TWD	79.33%
Standard Chem & Pharm CO., LTD.	1.46 Billion TWD	14.836%
Maywufa Company Ltd.	854.37 Million TWD	-46.114%
ScinoPharm Taiwan, Ltd.	901.49 Million TWD	-38.476%
Lotus Pharmaceutical Co., Ltd.	4.48 Billion TWD	72.14%
LIWANLI Innovation Co., Ltd.	54.86 Million TWD	-2175.278%
YungShin Global Holding Corporation	2.04 Billion TWD	39.036%
PhytoHealth Corporation	67.64 Million TWD	-1745.504%
SCI Pharmtech, Inc.	190.02 Million TWD	-556.949%
PharmaEssentia Corporation	4.49 Billion TWD	72.228%
Bora Pharmaceuticals Co., LTD.	1.74 Billion TWD	28.342%

Global Stocks Search

Formosa Laboratories, Inc. (4746.TW)

Operating Expenses Summary of Formosa Laboratories, Inc.

Annual Operating Expenses Chart of Formosa Laboratories, Inc. (2023 - 2009)

Historical Annual Operating Expenses of Formosa Laboratories, Inc. (2023 - 2009)

Peer Operating Expenses Comparison of Formosa Laboratories, Inc.